Source / information
Disclosure:
The study is funded by the National Institute of Diabetes and Digestive and Kidney Diseases of the NIH. Healio Primary Care was unable to confirm any other relevant financial information at the time of publication.
ADD SUBJECT TO EMAIL ALERTS
Receive an email when new articles are published
Please enter your email address to receive an email when new articles are published on . “data-action = subscribe> Subscribe
We could not process your request. Please try again later. If this problem persists, please contact customerservice@slackinc.com.
Back to Healio
The NIH recently started a new study to learn more about changes in glucose during pregnancy.
The study – Glycemic Observation and Metabolic Outcomes in Mothers and Offspring Study (GO MOMs) – aims to improve approaches to the screening, diagnosis and treatment of elevated blood sugar in pregnant patients Barbara Linder, MD, PhD, Project scientist for GO MOMs.
The NIH has started a new study to determine the optimal time to screen for gestational diabetes. Photo source: Shutterstock
“By learning more about glucose levels during pregnancy, we can identify potential early indicators of gestational diabetes and determine the best time to screen and treat it,” says Linder, who is also the program director of the Department of Diabetes, Endocrinology and Metabolic Diseases. The National Institute of Diabetes and Digestive and Kidney Diseases of the NIH announced in a press release.
Currently, gestational diabetes is often diagnosed between the 24th and 28th week of pregnancy, according to the NIH.
“By the time people are currently screened for gestational diabetes, it may be too late to avoid the long-lasting health effects.” William L. Lowe Jr., MD, Professor of Medicine at Northwestern University’s Feinberg School of Medicine and Chair of GO MOMs, said in the press release. “We hope to recruit a diverse group of GO MOMs attendees to identify important changes during pregnancy and see if there are any associations with a subsequent gestational diabetes diagnosis and large birth size of the offspring.”
The researchers aim to include approximately 2,150 people without diabetes who are in the first trimester of pregnancy. They will use continuous glucose monitoring technology to record participants’ blood sugar throughout their pregnancy.
The results will build on previous NIH-funded studies HAPO and HAPO-FUS, which showed that people with elevated blood sugar during pregnancy were significantly more likely to develop type 2 diabetes or prediabetes than people without elevated blood sugar during pregnancy it in the publication. HAPO-FUS data also showed that children born to mothers with elevated blood sugar during pregnancy were more likely to be obese and impaired glucose metabolism 10 years later.
Northwestern University will serve as the coordination center and study location for GO MOMs. Other study locations are:
- Columbia University;
- Kaiser Center for Health Research, Honolulu;
- Kaiser Center for Health Research NW, Portland, Oregon;
- Magee Women’s Hospital, Pittsburgh;
- Massachusetts General Hospital;
- Tufts Medical Center, Boston;
- Rhode Island Women’s and Infant Hospital, Providence; and
- Yale University.
The course is now open for enrollment. To learn more, click here.
ADD SUBJECT TO EMAIL ALERTS
Receive an email when new articles are published
Please enter your email address to receive an email when new articles are published on . “data-action = subscribe> Subscribe
We could not process your request. Please try again later. If this problem persists, please contact customerservice@slackinc.com.
Back to Healio
